|
RAB35 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.935700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.420200E-01 |
| Normal-vs-Stage2 |
1.122620E-01 |
| Normal-vs-Stage3 |
4.057800E-02 |
| Normal-vs-Stage4 |
5.654000E-02 |
| Stage1-vs-Stage2 |
3.876000E-01 |
| Stage1-vs-Stage3 |
1.773560E-01 |
| Stage1-vs-Stage4 |
2.168800E-01 |
| Stage2-vs-Stage3 |
8.996600E-01 |
| Stage2-vs-Stage4 |
7.862400E-01 |
| Stage3-vs-Stage4 |
8.545400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.322360E-01 |
| Normal-vs-AfricanAmerican |
9.775800E-01 |
| Normal-vs-Asian |
7.899200E-01 |
| Caucasian-vs-AfricanAmerican |
3.825000E-01 |
| Caucasian-vs-Asian |
3.732400E-01 |
| AfricanAmerican-vs-Asian |
8.561200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.772500E-02 |
| Normal-vs-Female |
1.310450E-01 |
| Male-vs-Female |
2.513000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.124400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.071800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.129760E-02 |
| Normal-vs-Age(81-100Yrs) |
3.868200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.107500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.414150E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.909200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.938800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.578600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.914000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.124180E-01 |
| Classical-VS-Follicular |
8.31659999978029E-07 |
| Classical-VS-Other |
9.818600E-03 |
| Classical-VS-Normal |
7.491400E-01 |
| Tall-VS-Follicular |
1.004010E-01 |
| Tall-VS-Other |
1.189590E-01 |
| Tall-VS-Normal |
9.564200E-02 |
| Follicular-VS-Other |
5.629000E-01 |
| Follicular-VS-Normal |
3.85670000000449E-05 |
| Other-VS-Normal |
5.180200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.429900E-02 |
| Normal-vs-N1 |
9.155700E-03 |
| N0-vs-N1 |
2.725200E-01 |
|
|
